d-alpha tocopherol has been researched along with Genetic Diseases, X-Chromosome Linked in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Elokely, KM; Haron, MH; Klein, ML; Manandhar, A; Ross, SA | 1 |
| Birch, DG; Hoffman, DR; Locke, KG; Watkins, RB; Wheaton, DH | 1 |
1 trial(s) available for d-alpha tocopherol and Genetic Diseases, X-Chromosome Linked
| Article | Year |
|---|---|
Biological safety assessment of docosahexaenoic acid supplementation in a randomized clinical trial for X-linked retinitis pigmentosa.
Topics: Adolescent; Adult; Alanine Transaminase; Antioxidants; Biological Availability; Child; Child, Preschool; Cholesterol; Dietary Supplements; Disease Progression; Docosahexaenoic Acids; Double-Blind Method; Fatty Acids; Genetic Diseases, X-Linked; Humans; Lipoproteins; Male; Platelet Aggregation; Retinitis Pigmentosa; Safety; Triglycerides; Vitamin A; Vitamin E | 2003 |
1 other study(ies) available for d-alpha tocopherol and Genetic Diseases, X-Chromosome Linked
| Article | Year |
|---|---|
Potential Pro-Inflammatory Effect of Vitamin E Analogs through Mitigation of Tetrahydrocannabinol (THC) Binding to the Cannabinoid 2 Receptor.
Topics: Dronabinol; Electronic Nicotine Delivery Systems; Genetic Diseases, X-Linked; Receptors, Cannabinoid; Thrombocytopenia; Vaping; Vitamin E | 2022 |